In a new study published in Clinical Gastroenterology and Hepatology, the low FODMAP diet and the antibiotic rifaximin ...

Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today ...

A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...

Experts say treating irritable bowel syndrome with a coordinated team may improve symptoms and quality of life more ...

A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable bowel syndrome (IBS)—including ...

April is IBS Awareness Month. Learn about irritable bowel syndrome symptoms, diagnosis, and treatment options.

A massive long-term study tracking more than 650,000 Americans with irritable bowel syndrome is raising new concerns about the safety of some commonly used treatments.

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal conditions you can get. It’s defined as abdominal pain or discomfort with, ahem, “altered” bowel habits over a period of time.

There is no known cure for IBS, but some treatments can reduce and manage symptoms. These treatments include combinations of diet, medications, fiber supplements, lifestyle modifications, and ...

Please provide your email address to receive an email when new articles are posted on . At 4 weeks, the dietary interventions reduced symptom severity in 76% and 71% of patients vs. 58% on medical ...

Researchers say some medications prescribed for irritable bowel syndrome (IBS) may increase a person’s risk of early death.